Richard A. Norman
Publications by Year
Research Areas
Estrogen and related hormone effects, Fibroblast Growth Factor Research, Eosinophilic Disorders and Syndromes, Chronic Myeloid Leukemia Treatments, Cancer therapeutics and mechanisms
Most-Cited Works
- → N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor(2006)362 cited
- → Computational approaches to therapeutic antibody design: established methods and emerging trends(2019)228 cited
- → AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1 -Mutant Breast Tumors in Preclinical Models(2016)174 cited
- → Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation(2012)169 cited
- → Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist(2015)159 cited
- → Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4(2014)119 cited
- → Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use(2016)115 cited
- → Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation(2003)114 cited
- → Crystal Structure of Human Thymidine Phosphorylase in Complex with a Small Molecule Inhibitor(2004)98 cited
- → The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence(2003)95 cited